The Role of MRI and PET/CT in Radiotherapy Target Volume Determination in Gastrointestinal Cancers-Review of the Literature
- PMID: 37296929
- PMCID: PMC10252061
- DOI: 10.3390/cancers15112967
The Role of MRI and PET/CT in Radiotherapy Target Volume Determination in Gastrointestinal Cancers-Review of the Literature
Abstract
Positron emission tomography with computed tomography (PET/CT) and magnetic resonance imaging (MRI) could improve accuracy in target volume determination for gastrointestinal cancers. A systematic search of the PubMed database was performed, focusing on studies published within the last 20 years. Articles were considered eligible for the review if they included patients with anal canal, esophageal, rectal or pancreatic cancer, as well as PET/CT or MRI for radiotherapy treatment planning, and if they reported interobserver variability or changes in treatment planning volume due to different imaging modalities or correlation between the imaging modality and histopathologic specimen. The search of the literature retrieved 1396 articles. We retrieved six articles from an additional search of the reference lists of related articles. Forty-one studies were included in the final review. PET/CT seems indispensable for target volume determination of pathological lymph nodes in esophageal and anal canal cancer. MRI seems appropriate for the delineation of primary tumors in the pelvis as rectal and anal canal cancer. Delineation of the target volumes for radiotherapy of pancreatic cancer remains challenging, and additional studies are needed.
Keywords: MRI; PET/CT; anal canal cancer; esophageal cancer; interobserver variability; pancreatic cancer; rectal cancer; target volume determination.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Variability of gross tumour volume delineation: MRI and CT based tumour and lymph node delineation for lung radiotherapy.Radiother Oncol. 2022 Feb;167:292-299. doi: 10.1016/j.radonc.2021.11.036. Epub 2021 Dec 8. Radiother Oncol. 2022. PMID: 34896156
-
Comparison of 68 Ga-PSMA ligand PET/CT versus conventional cross-sectional imaging for target volume delineation for metastasis-directed radiotherapy for metachronous lymph node metastases from prostate cancer.Strahlenther Onkol. 2019 May;195(5):420-429. doi: 10.1007/s00066-018-1417-9. Epub 2019 Jan 4. Strahlenther Onkol. 2019. PMID: 30610354 English.
-
Variabilities of Magnetic Resonance Imaging-, Computed Tomography-, and Positron Emission Tomography-Computed Tomography-Based Tumor and Lymph Node Delineations for Lung Cancer Radiation Therapy Planning.Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):80-89. doi: 10.1016/j.ijrobp.2017.05.002. Epub 2017 May 6. Int J Radiat Oncol Biol Phys. 2017. PMID: 28816167 Free PMC article.
-
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2.Crit Rev Oncol Hematol. 2019 Jul;139:117-124. doi: 10.1016/j.critrevonc.2019.03.008. Epub 2019 Mar 20. Crit Rev Oncol Hematol. 2019. PMID: 30940428 Review.
-
Positron emission tomography for radiation treatment planning.Strahlenther Onkol. 2005 Aug;181(8):483-99. doi: 10.1007/s00066-005-1422-7. Strahlenther Onkol. 2005. PMID: 16044216 Review.
Cited by
-
Chromatin Remodeling-Related PRDM1 Increases Stomach Cancer Proliferation and Is Counteracted by Bromodomain Inhibitor.J Pers Med. 2024 Feb 20;14(3):224. doi: 10.3390/jpm14030224. J Pers Med. 2024. PMID: 38540967 Free PMC article.
-
Interstitial HDR brachytherapy for anal cancer-results and quality of life.Strahlenther Onkol. 2025 Jul;201(7):687-698. doi: 10.1007/s00066-024-02316-5. Epub 2024 Nov 14. Strahlenther Onkol. 2025. PMID: 39542884 Free PMC article.
-
Integrating Imaging and Circulating Tumor DNA Features for Predicting Patient Outcomes.Cancers (Basel). 2024 May 15;16(10):1879. doi: 10.3390/cancers16101879. Cancers (Basel). 2024. PMID: 38791958 Free PMC article. Review.
References
-
- World Health Organization International Agency for Research on Cancer (IARC) GLOBOCAN 2020: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2020. [(accessed on 20 January 2023)]. Available online: http://globocan.iarc.fr/
Publication types
LinkOut - more resources
Full Text Sources